Product Details for: Leqembi IQLIK

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
360MG/1.8ML (200MG/ML)
Autoinjector
351(a)
Leqembi IQLIK
Rx
002
Injection
Subcutaneous
250MG/1.25ML (200MG/ML)
Autoinjector
351(a)
Leqembi IQLIK
Rx
Proper Name
lecanemab-irmb
BLA Number
761375
Applicant
Eisai, Incorporated
Original Approval Date
August 29, 2025
Date of First Licensure
RETURN TO SEARCH RESULTS